Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Fridman

Showing results (21-30 of 300) with videos related to

Pageof 30
Sort By:
Research in Immunology|March 1, 1989
Are Ts cells involved in isotype-specific regulation?J L Teillaud, W H Fridman
Cellular Immunology|April 1, 1976
Inhibition of the in vitro 19S and 7S antibody response by immunoglobulin-binding factor (IBF) from alloantigen-activated T cellsR H Gisler, W H Fridman
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1977
Characterization of suppressive immunoglobulin-binding factor (IBF). II. Purification and molecular weight determination of IBF produced by L-5178-Y theta-positive lymphomaC Neauport-Sautes, W H Fridman
The Journal of Experimental Medicine|August 1, 1975
Suppression of in vitro antibody synthesis by immunoglobulin-binding factorR H Gisler, W H Fridman
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
Identification, molecular cloning, biologic properties, and tissue distribution of a novel isoform of murine low-affinity IgG receptor homologous to human Fc gamma RIIB1S Latour, W H Fridman, M Daëron
Journal De Biologie Buccale|March 1, 1992
[Demonstration of soluble IgG-Fc type II receptors (or s-Fc-gamma-II-R) in human whole saliva]C Teillaud, W H Fridman, C Sautes
Cellular Immunology|February 1, 1984
Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cellsM Lakhdar, A Senik, W H Fridman
Immunology Letters|May 1, 1994
Mechanism of inhibition of lipopolysaccharide-stimulated mouse B-cell responses by transforming growth factor-beta 1C Bouchard, W H Fridman, C Sautès
Annales De L'Institut Pasteur. Immunology|September 1, 1986
Fc receptor diversity: the mast cell caseM Daëron, M Benhamou, W H Fridman
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
Effect of TGF-beta1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytesC Bouchard, W H Fridman, C Sautès
Pageof 30

Showing results (21-30 of 300) with videos related to

Sort By:
Pageof 30
Research in Immunology|March 1, 1989
Are Ts cells involved in isotype-specific regulation?J L Teillaud, W H Fridman
Cellular Immunology|April 1, 1976
Inhibition of the in vitro 19S and 7S antibody response by immunoglobulin-binding factor (IBF) from alloantigen-activated T cellsR H Gisler, W H Fridman
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1977
Characterization of suppressive immunoglobulin-binding factor (IBF). II. Purification and molecular weight determination of IBF produced by L-5178-Y theta-positive lymphomaC Neauport-Sautes, W H Fridman
The Journal of Experimental Medicine|August 1, 1975
Suppression of in vitro antibody synthesis by immunoglobulin-binding factorR H Gisler, W H Fridman
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
Identification, molecular cloning, biologic properties, and tissue distribution of a novel isoform of murine low-affinity IgG receptor homologous to human Fc gamma RIIB1S Latour, W H Fridman, M Daëron
Journal De Biologie Buccale|March 1, 1992
[Demonstration of soluble IgG-Fc type II receptors (or s-Fc-gamma-II-R) in human whole saliva]C Teillaud, W H Fridman, C Sautes
Cellular Immunology|February 1, 1984
Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cellsM Lakhdar, A Senik, W H Fridman
Immunology Letters|May 1, 1994
Mechanism of inhibition of lipopolysaccharide-stimulated mouse B-cell responses by transforming growth factor-beta 1C Bouchard, W H Fridman, C Sautès
Annales De L'Institut Pasteur. Immunology|September 1, 1986
Fc receptor diversity: the mast cell caseM Daëron, M Benhamou, W H Fridman
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 1997
Effect of TGF-beta1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytesC Bouchard, W H Fridman, C Sautès
Pageof 30